Longstanding Phenytoin Use as a Cause of Progressive Dyspnea.
Chest
; 161(2): e91-e96, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1664780
ABSTRACT
CASE PRESENTATION A 54-year-old South African man with a medical history of type 2 diabetes mellitus, seizure disorder, OSA, and latent TB presented to the ER with gradually progressive dyspnea over months. He also reported occasional dry cough and fatigue at presentation but denied fever, chills, chest pain, leg swelling, palpitations, or lightheadedness. He was treated with a course of levofloxacin for presumed community-acquired pneumonia as an outpatient without improvement and had tested negative for COVID-19. He denied occupational or environmental exposures or sick contacts, though he had traveled back to South Africa 1 year before presentation. He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily). His other home medications included dulaglutide, sertraline, and atorvastatin and had no recent changes. He quit smoking 30 years ago after smoking one pack per day for 10 years.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Fenitoína
/
Convulsiones
/
Enfermedades Pulmonares Intersticiales
/
Sustitución de Medicamentos
/
Lacosamida
/
COVID-19
/
Pulmón
Tipo de estudio:
Reporte de caso
/
Estudios diagnósticos
/
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Chest
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS